1) Molecular profiling may help determine patient’s response to cancer therapies, research suggests.
2 )Scientists developing new techniques for detecting CTCs in cancer patients’ blood-Medscape report
3) Bladder cancer cells may have two distinct genetic patterns, research suggests.
4) Immune cells could be reprogrammed to attack prostate cancer, scientists say.
5) Researchers say presence of certain variants in MC1R gene may increase melanoma risk.